I think one day maybe we can cure all diseases with the help of AI. Maybe within the next decade or so, I don't see why not. — Demis Hassabis, Nobel Laureate in Chemistry & CEO of Google DeepMind (said on 20 April 2025)
CBS 60 Minutes transcript

Progress Snapshot

📅 On 20 Apr 2025: 5/100

📍 Today: 12/100

📈 Progress: +7%

The Ten Year Journey

Today (2%)
Apr 2025 Apr 2035
Fun, speculative content created by AI - not definitive information.

🌟 Recent Wins

🩸

Cancer Blood Test

An AI blood test spots 12 common cancers from a few drops of blood. First NHS trial results look promising.

(21 May 2025, Source: 2MM AI Roundup, Credibility: 6/10)

🏥

Safer Hospitals

AI sensors warn nurses before a patient may fall. Emory Hospital cut falls by about one‑fifth since rollout.

(21 May 2025, Source: 2MM AI Roundup, Credibility: 6/10)

🧬

DNA Liquid Biopsy

A quick blood test matches cancers to the right drug in days. NHS England is rolling it out nationwide.

(29 May 2025, Source: The Guardian, Credibility: 7/10)

💉

AI Antibody Drug

GV20‑0251, picked by AI, shrank tumours in early human tests. More patients are joining now.

(04 Jun 2025, Source: PR Newswire, Credibility: 5/10)

🧠

Brain Disease Bot

An AI assistant beat doctors at spotting rare balance disorders, scoring 91% vs 18%.

(15 May 2025, Source: Nature Rev. Neurology, Credibility: 8/10)

🤖

Therapy Chatbot

Limbic's chatbot helped people stick with therapy and recover faster at NHS clinics.

(21 May 2025, Source: 2MM AI Roundup, Credibility: 6/10)

💰

Faster Drug Labs

Insilico raised $110 M to expand its robot‑AI labs. Two AI‑made cancer drugs enter trials this year.

(21 May 2025, Source: 2MM AI Roundup, Credibility: 5/10)

🦿

Mind‑Controlled Hand

Brain‑wave signals drove robot fingers in real time with 80% accuracy in volunteers.

(01 Jul 2025, Source: Nature Communications, Credibility: 7/10)

💪

Smart Exoskeleton

A deep‑learning exoskeleton reads muscle signals and predicts movement with 97% accuracy.

(30 May 2025, Source: Scientific Reports, Credibility: 7/10)

Sources for Further Reading

view count